These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1314691

  • 21. Serum soluble interleukin-2 receptor alpha levels in patients with gynecologic cancers: early effect of surgery.
    Barton DP, Blanchard DK, Michelini-Norris B, Roberts WS, Hoffman MS, Fiorica JV, Nicosia SV, Cavanagh D, Djeu JY.
    Am J Reprod Immunol; 1993; 30(2-3):202-6. PubMed ID: 8311929
    [Abstract] [Full Text] [Related]

  • 22. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
    Hsu MM, Chen YJ, Chang YL, Ko JY, Sheen TS.
    Asian Pac J Allergy Immunol; 1995 Jun; 13(1):1-4. PubMed ID: 7488337
    [Abstract] [Full Text] [Related]

  • 23. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
    Wang L, Wang JH, Liu WJ, Wang WD, Wang H, Chen XQ, Geng QR, Lu Y, Xia ZJ.
    Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
    [Abstract] [Full Text] [Related]

  • 24. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M, Darwish NA, Abdel-Aziz O.
    J Soc Gynecol Investig; 1996 Dec; 3(1):39-46. PubMed ID: 8796806
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
    Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR.
    Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
    [Abstract] [Full Text] [Related]

  • 28. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
    Akiyama K, Tsuji M, Kurokawa Y, Yokota K, Kojima K, Naruo S, Kanayana HO, Kagawa S.
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
    [Abstract] [Full Text] [Related]

  • 29. Changes in serum soluble IL-2 receptors (sIL-2R) and immunosuppressive acidic protein (IAP) associated with chemotherapy for lung cancer.
    Katoh R, Takenoshita S, Shimizu Y, Tanaka S, Yajima Y, Nagamachi Y.
    Anticancer Res; 1997 Apr; 17(5B):3787-92. PubMed ID: 9427781
    [Abstract] [Full Text] [Related]

  • 30. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H.
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
    Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M.
    Cancer; 1994 Jun 01; 73(11):2753-8. PubMed ID: 8194016
    [Abstract] [Full Text] [Related]

  • 33. Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
    Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, Fornier M, Devizzi L, Verderio P, Valagussa P, Bonadonna G.
    Br J Cancer; 1998 Mar 01; 77(6):992-7. PubMed ID: 9528846
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Plasma soluble interleukin-2 receptor levels during and after upper abdominal surgery.
    Kato M, Kurosawa S, Matsuoka H, Murakami M, Imai R, Takahashi M.
    Anaesth Intensive Care; 2000 Dec 01; 28(6):650-3. PubMed ID: 11153291
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome.
    Ambrosetti A, Nadali G, Vinante F, Carlini S, Veneri D, Todeschini G, Morosato L, de Sabata D, Chilosi M, Maggi E.
    Cancer; 1993 Jul 01; 72(1):201-6. PubMed ID: 8508408
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Indices of immune activation after bronchial carcinoma surgery.
    Sawa A, Kozioł-Montewka M, Goździuk K, Roliński J, Iłzecki M.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Jul 01; 58(1):161-6. PubMed ID: 15314978
    [Abstract] [Full Text] [Related]

  • 40. Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
    Nakata B, Chung KH, Kato Y, Yamashita Y, Inui A, Arimoto Y, Maeda K, Onoda N, Sawada T, Sowa M.
    Br J Cancer; 1998 Jun 01; 77(11):1820-4. PubMed ID: 9667652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.